Detecting lung cancer in plasma with the use of multiple genetic markers
Open Access
- 7 October 2003
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 108 (1), 91-96
- https://doi.org/10.1002/ijc.11510
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?The Journal of Pathology, 2002
- The IARC TP53 database: New online mutation analysis and recommendations to usersHuman Mutation, 2002
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- Heterogeneous tumor clones as an explanation of discordance between plasma DNA and tumor DNA alterationsGenes, Chromosomes and Cancer, 2001
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999
- The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adductsOncogene, 1998
- Preferential Formation of Benzo[ a ]pyrene Adducts at Lung Cancer Mutational Hotspots in P53Science, 1996
- The FHIT Gene at 3p14.2 Is Abnormal in Lung CancerCell, 1996
- Molecular Detection of Primary Bladder Cancer by Microsatellite AnalysisScience, 1996
- Determination of circulating DNA levels in patients with benign or malignant gastrointestinal diseaseCancer, 1983